[Hematologic malignancies in internal medicine, University Hospital of Souro Sanou (Burkina Faso)].
Hematologic malignancies (HM) in internal medicine remain undocumented, both epidemiological aspects, diagnosis, therapeutic that evolutionary. An inventory of sites, will document these aspects, to identify highly lethal forms, and thus contribute to improving the management of HM in a hospital in a developing country. A cross-sectional retrospective study referred to descriptive over two and a half years, from review of patients' medical records allowed an exhaustive census of 58 cases of HM admitted to the Department of Internal Medicine of University Hospital Souro Sanou (UHC SS). The first reason for consultation were abdominal tumor syndrome (63.7%). The average age of patients was 42 ± 19.7 years with extremes ranging from 16 to 87 years. The sex ratio was 1.42: 1. Hematological disturbances were strongly suspected anemia (89.2%), leukocytosis (64.3%) and thrombocytopenia (46.4%). The HM depending on cytology were dominated by lymphomas (48.2%) followed by chronic myeloid leukemia or 15.5%. Chemotherapy was undertaken in 63.7% of cases. Lethality was 23.1%, was significantly higher for acute leukemia 40% (p = 0.0012). HIV serology was positive in 3 patients among the 13 cases tested. This study provided a better understanding of HM epidemiology at the UHC SS in the department of internal medicine. It revealed a predominance of lymphomas with difficulties in the initiation of chemotherapy. Improving access to chemotherapy, and technical support enable a reduction in the fatality associated with HM in the department of internal medicine at UHC SS.